CPEB3 regulates the proliferation and apoptosis of bovine cumulus cells-Reference-Cited by-同舟云学术

CPEB3 regulates the proliferation and apoptosis of bovine cumulus cells

Published:2020-01 Issue:1 Volume:91 Page:
ISSN:1344-3941
Container-title:Animal Science Journal
language:en
Short-container-title:Anim Sci J

Author:

Wang Ying¹^ORCID,Chen Cheng‐Zhen¹^ORCID,Fu Xu‐Huang¹,Liu Jian‐Bo¹,Peng Yan‐Xia¹,Wang Yi‐Jie¹,Han Dong‐Xu¹,Zhang Zhe¹,Yuan Bao¹^ORCID,Gao Yan¹^ORCID,Jiang Hao¹^ORCID,Zhang Jia‐Bao¹^ORCID

Affiliation:

1. Department of Laboratory Animals Jilin Provincial Key Laboratory of Animal Model Jilin University Changchun Jilin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Agricultural and Biological Sciences,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/asj.13416

Reference58 articles.

1. Human cumulus cells as biomarkers for embryo and pregnancy outcomes

2. Control of cell cycle transcription during G1 and S phases

3. CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation

4. Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation

5. Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CPEB3 Maintains Developmental Competence of the Oocyte;Cells;2024-05-16

2. Understanding the Mechanisms of Diminished Ovarian Reserve: Insights from Genetic Variants and Regulatory Factors;Reproductive Sciences;2024-02-12

3. Identification of RNA-binding Proteins in Spinal Cord Injury: An In-silico Approach;ICMST;2023-08-10

4. Advances in Oocyte Maturation In Vivo and In Vitro in Mammals;International Journal of Molecular Sciences;2023-05-21

5. Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease;Biomedicines;2022-06-14